Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2010 2
2011 3
2012 2
2013 2
2014 1
2016 1
2017 1
2018 2
2019 3
2020 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).
Antolín Novoa S, Escrivá-de-Romaní S, Tolosa Ortega P, Oliva Fernández L, López López R, López González A, de la Morena Barrio P, Echavarria Díaz-Guardamino I, Alés Martinez JE, Garate Z, González-Cortijo L. Antolín Novoa S, et al. Among authors: lopez gonzalez a. Cancer Treat Res Commun. 2023;37:100772. doi: 10.1016/j.ctarc.2023.100772. Epub 2023 Nov 1. Cancer Treat Res Commun. 2023. PMID: 37995519 Free article.
Disease-modifying treatments for patients with multiple sclerosis in Spain.
Pérez AS, Casado SE, Álvarez Payero M, Escolano Pueyo ÁE, Arévalo Bernabé ÁG, Padullés Zamora N, Diaz Ruiz P, López González AM. Pérez AS, et al. Among authors: lopez gonzalez am. Farm Hosp. 2023 Jul-Aug;47(4):155-160. doi: 10.1016/j.farma.2023.03.009. Epub 2023 May 2. Farm Hosp. 2023. PMID: 37142541 Free article. English, Spanish.
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
López González A, Del Barco Berrón S, Grau I, Galan M, Castelo Fernández B, Cortés A, Sánchez Rovira P, Martinez-Bueno A, Gonzalez X, García A, Gener P, Mina L, Alcalá-López D, Sampayo M, Cortés J, Pérez-Garcia JM, Llombart-Cussac A, López-Miranda E. López González A, et al. Cancers (Basel). 2022 Nov 29;14(23):5880. doi: 10.3390/cancers14235880. Cancers (Basel). 2022. PMID: 36497361 Free PMC article.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Prat A, Paz-Ares L, Juan M, Felip E, Garralda E, González B, Arance A, Martín-Liberal J, Gavilá J, López-González A, Cejalvo JM, Izarzugaza Y, Amillano K, Corbacho JG, Saura C, Racca F, Hierro C, Sanfeliu E, Gonzalez X, Canes J, Villacampa G, Salvador F, Pascual T, Mesía R, Cervantes A, Tabernero J. Prat A, et al. Among authors: lopez gonzalez a. Future Oncol. 2022 Oct 6. doi: 10.2217/fon-2022-0660. Online ahead of print. Future Oncol. 2022. PMID: 36200668 Review.
Relationship between Aldehyde Dehydrogenase, PD-L1 and Tumor-Infiltrating Lymphocytes with Pathologic Response and Survival in Breast Cancer.
López Flores M, Honrado Franco E, Sánchez Cousido LF, Minguito-Carazo C, Sanz Guadarrama O, López González L, Vallejo Pascual ME, Molina de la Torre AJ, García Palomo A, López González A. López Flores M, et al. Among authors: lopez gonzalez a. Cancers (Basel). 2022 Sep 11;14(18):4418. doi: 10.3390/cancers14184418. Cancers (Basel). 2022. PMID: 36139578 Free PMC article.
EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain.
Delgado Sillero I, Lopetegui Lia N, Sánchez Cousido LF, Rojas Piedra M, Távara Silva B, Garrido Onecha ML, Medina Valdivieso S, Alonso Horcajo N, Díez Tascón C, López González A, Castañón López C, Pedraza Lorenzo M, García Palomo A, Martín V, Diz Tain P. Delgado Sillero I, et al. Among authors: lopez gonzalez a. J Oncol Pharm Pract. 2023 Jun;29(4):854-860. doi: 10.1177/10781552221085253. Epub 2022 Mar 21. J Oncol Pharm Pract. 2023. PMID: 35306915
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Adamo B, Bellet M, Paré L, Pascual T, Vidal M, Pérez Fidalgo JA, Blanch S, Martinez N, Murillo L, Gómez-Pardo P, López-González A, Amillano K, Canes J, Galván P, González-Farré B, González X, Villagrasa P, Ciruelos E, Prat A. Adamo B, et al. Among authors: lopez gonzalez a. Breast Cancer Res. 2019 Sep 18;21(1):108. doi: 10.1186/s13058-019-1195-z. Breast Cancer Res. 2019. PMID: 31533777 Free PMC article. Clinical Trial.
Fatty acid intake and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain).
Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Gracia-Lavedan E, Pérez-Gómez B, Oribe M, Martín V, Guevara M, Rodríguez-Cundín P, Fernández-Tardón G, Marcos-Gragera R, Molina-Barceló A, Díaz-Santos M, Castaño-Vinyals G, Aragonés N, López-Gonzalez A, Amiano P, Castilla J, Alonso-Molero J, Kogevinas M, Pollán M, Llorca J. Dierssen-Sotos T, et al. Among authors: lopez gonzalez a. Eur J Nutr. 2020 Apr;59(3):1171-1179. doi: 10.1007/s00394-019-01977-8. Epub 2019 May 8. Eur J Nutr. 2020. PMID: 31069457
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
Manso L, Moreno Antón F, Izarzugaza Perón Y, Delgado Mingorance JI, Borrega García P, Echarri González MJ, Martínez-Jañez N, López-González A, Olier Garate C, Ballesteros García A, Chacón López-Muñíz I, Ciruelos Gil E, García-Sáenz JA, Paz-Ares L. Manso L, et al. Among authors: lopez gonzalez a. Breast J. 2019 Mar;25(2):219-225. doi: 10.1111/tbj.13199. Epub 2019 Feb 8. Breast J. 2019. PMID: 30734437 Clinical Trial.
A Higher Fructose Intake Is Associated with Greater Albuminuria in Subjects with Type 2 Diabetes Mellitus.
Gómez-Sámano MÁ, Almeda-Valdes P, Cuevas-Ramos D, Navarro-Flores MF, Espinosa-Salazar HD, Martínez-Saavedra M, León-Domínguez JA, Enríquez-Estrada VM, López-González AL, Sarmiento-Moreno AL, Rivera-González LA, Juárez-León ÓA, Pérez-González B, Ávila-Palacios Y, Sigala-Pedroza L, Huerta-Ávila E, Vargas-Álvarez MA, Sánchez-Jaimes C, Cárdenas-Vera M, Mehta R, López-Flores A La Torre MA, Manjarrez-Martínez I, Brito-Córdova GX, Zuarth-Vázquez JM, Vega-Beyhart A, López-Carrasco G, Johnson RJ, Gómez-Pérez FJ. Gómez-Sámano MÁ, et al. Among authors: lopez gonzalez al. Int J Nephrol. 2018 Oct 17;2018:5459439. doi: 10.1155/2018/5459439. eCollection 2018. Int J Nephrol. 2018. PMID: 30416829 Free PMC article.
24 results